9TH HIV and Women 2019 – Presentations

 

Day 1 - Saturday, 2 March 2019

 Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy
Chairs: Catherine Hankins and Karoline Aebi-Popp
 

Gaolathe, Tendani 2019 120x160Clinical case: Researcher perspective

Tendani Gaolathe, MD - Botswana Harvard AIDS Institute Partnership, Botswana

 

 
 

Clinical case: Community perspective
No slides available
Lucy Wanjiku Njenga - Positive Young Women Voices, Kenya

 

 
 

Clinical case: Policy implications

Meg Doherty, MD, PhD - WHO, UK

 

 
   
 Abstract-driven presentations
Note:
Videos are not available for abstract-driven presentations
 
 

INSTI exposure and neural tube defects – data from antiretroviral pregnancy registry
Jessica Albano, PhD, MPH - Syneos Health, USA

#1
 

Congenital anomalies in infants of Canadian women exposed to antiretrovirals including dolutegravir
Deborah Money, MD - UBC, Canada

#2
 

Evaluation of neural tube defects after exposure to Raltegravir during pregnancy
Hala Shamsuddin, MD - Merck, USA

#3
   
 Session 2: New drug delivery systems, are they right for women?
Chair: Sharon Walmsley
 

Invited lecture, focus on cabotegravir
No slides or video available

Annemiek de Ruiter, MBBS FRCP, MD, ViiV Healthcare, UK

 
 

Emerging drug delivery systems for treatment and prevention of HIV

Kimberly Scarsi, PharmD, MS, University of Nebraska, USA

 

 
 Abstract-driven presentations
Note: 
Videos are not available for abstract-driven presentations
 
 

Clinical development strategy to inform dosing of antiretroviral drugs in women: dolutegravir as a case study
Kimberly Adkison, PhD - Viiv Healthcare, USA

#4
 

HIV risk and characteristics of women seeking PrEP in a US demonstration project
Jill Blumenthal, MD - University of California, San Diago, USA

#5
   
 Session 3: Unique challenges of growing up with HIV
Chairs: Angelina Namiba and Teresia Otieno
 No available presentations due to confidentiality 
 Abstract-driven presentations
Note: 
Videos are not available for abstract-driven presentations
 
 High PrEP uptake among HIV-exposed women with pregnancy plans in South Africa
Lynn Matthews, MD - University of Alabama at Birmingham, USA
#7
 Innovative intervention for pregnant and breastfeeding adolescent mothers to enhance viral suppression in Homa Bay County, Kenya
Elizabeth Okoth (presented by N. Rakhmanina), MPH -
Elizabeth Glaser Pediatric AIDS Foundation, Kenya
#8
   
 

Day 2 - Sunday, 3 March 2019

 Session 4: Healthy aging with HIV for women
Chair: Margaret Johnson
 

Bone Health among women aging with HIV

Michael Yin, MD, New York State Psychiatric Institute & Columbia University, USA

 

 
 Cardiac Muscle Health Among Women Aging with HIV

 

Markella Zanni, MD, MGH/Harvard Medical School, USA

 

 
 

Important Drug- Drug interactions in Women aging with HIV

Marta Boffito, MD, PhD, SSAT & Imperial College, Chelsea and Westminster Hospital, UK

 

 
   
 Session 5: Research in women and HIV - 1
Chairs:  Markella Zanni and Patricia Vasquez
Abstract-driven presentations
Note: Videos are not available for abstract-driven presentations

 Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIV
Elisabeth McClymont - University of British Columbia, Canada
#9
 Dolutegravir pharmacokinetics during pregnancy and postpartum
Angela Colbers, PhD - Radboud University Medical Center, The Netherlands
#10
 Intimate Partner Violence, Depression, and Mortality among a Cohort
of Women living with HIV Marginalized by Socio-structural Inequities
in Vancouver, Canada
Kalysha Closson - University Of British Columbia, Canada
#11
 Vaginal microbiome and associations with tenofovir diphosphate and lamivudine triphosphate in cervical tissues of Ugandan women
Melanie Nicol, PharmD, PhD - University of Minnesota, USA
 #12
   
 Session 6: HIV cure research - considerations for women
Chair: Natella Rakhmanina
 HIV Cure: Where have we been, where are we going?

 

Daniel Kuritzkes, MD,
Harvard Medical School, USA

 
 

Invited lecture:  Focus on women

Jintanat Ananworanich, MD, PhD,

US Military HIV Research Program, USA

 
 Abstract-driven presentations
Note: Videos are not available for abstract-driven presentations
 
 Women’s involvement in clinical research: Women included in Dolutegravir clinical trials versus collaborative studies
Romina Quercia, MD, PhD, MPH - ViiV Healthcare, UK
#13